* Abacus Life Inc ABL.OQ ABL.O is expected to report
resultson
August 12 for the period ending June 30 2024
* The Orlando Florida-based company is expected to report
revenue
of $26.708 million, according to the mean estimate from 3
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Abacus Life Inc is for
earnings of 13 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the multiline
insurance
& brokers peer group is also "Buy".
* Wall Street's median 12-month price target for Abacus Life
Inc
is $14.00, above its last closing price of $10.26.
This summary was machine generated August 9 at 19:24 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)